AXA Investment Managers’s Elevance Health ELV Stock Holding History

AXA Investment Managers’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$6.9M	Buy	+21,355	New	+$6.64M	0.02%	496

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

AXA Investment Managers's ELV Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Elevance Health (ELV) in Q3 2025: 21,355 shares worth $6.9M. The stake represents 0.02% of the portfolio and ranks #496 among its holdings.

1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

AXA Investment Managers held 21,355 shares of Elevance Health worth $6.9M as of Q3 2025.
Elevance Health was a new AXA Investment Managers position in Q3 2025.
Elevance Health made up 0.02% of AXA Investment Managers's portfolio in Q3 2025, its #496 holding.
1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.